---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-053715"
form_type: "8-K"
ticker: "KMTS"
cik: "0001877184"
company_name: "KESTRA MEDICAL TECHNOLOGIES, LTD."
filed_at: "2025-04-14T23:59:59+00:00"
generated_at: "2026-05-23T15:41:18.886124+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kestra Q3 revenue $15.1M (+82% YoY); FY2025 guided $58-58.5M

## Summary
- Revenue $15.1M in Q3 FY2025, up 82% YoY; gross margin improved to 43.4% from 10.6%.
- GAAP net loss $21.8M vs $21.6M prior year; adjusted EBITDA loss $16.3M vs $16.2M.
- Completed IPO in March 2025, raising net proceeds of $205.2M.
- In-network covered lives for ASSURE system now exceed 285M; appointed Al Ford as CCO.
- FY2025 revenue outlook $58M to $58.5M, representing 109%-110% growth vs FY2024.

## SEC filing metadata
- accession: 0000950170-25-053715
- form_type: 8-K
- ticker: KMTS
- cik: 0001877184
- company_name: KESTRA MEDICAL TECHNOLOGIES, LTD.
- filed_at: 2025-04-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/0000950170-25-053715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/ck0001877184-20250414.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-053715
- JSON: https://secwatch.observer/filing/0000950170-25-053715.json
- Plain text: https://secwatch.observer/filing/0000950170-25-053715.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.